Posted Dec. 10, 2012 at 5:39 a.m.
New York — Researchers will use induced pluripotent stem cells, which are adult stem cells that can be reprogrammed to generate any type of cell, because they probably have the genetic information needed for studying the diseases.Copyright 2013 Bloomberg. All rights reserved.
Sanofi, Pfizer, Roche, others plan $73M stem-cell bank
Post a comment
Print this blog postE-mail blog post
Share
New York — Researchers will use induced pluripotent stem cells, which are adult stem cells that can be reprogrammed to generate any type of cell, because they probably have the genetic information needed for studying the diseases.Copyright 2013 Bloomberg. All rights reserved.
Please Log In to add a comment.
Best of TechWire Insider
The Skinny
Durham's high-tech infrastructure, talent lure Virginia company
Lenovo acknowledges layoffs in Morrisville as part of shift to 'PC Plus' strategy
Raleigh-based PRA International eyes public offering
Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
Raleigh app developer StepLeader lands $4.4M in first fund raiser
IBM opens Linux center in China, says it will work with Red Hat
Red-hot Raleigh startup WedPics hauls in $1.1M in funding
New Triangle venture capital firm slowly emerging from shadows
Titans of tech seek to excite UNC, Duke grads about a future beyond themselves
Triangle politician tries to accelerate crowdfunding; bill passes first hurdle















